Pharmacologic Inhibition of mTOR Improves Lapatinib Sensitivity in HER2-Overexpressing Breast Cancer Cells with Primary Trastuzumab Resistance

Title
Pharmacologic Inhibition of mTOR Improves Lapatinib Sensitivity in HER2-Overexpressing Breast Cancer Cells with Primary Trastuzumab Resistance
Authors
Keywords
-
Journal
Anti-Cancer Agents in Medicinal Chemistry
Volume 12, Issue 2, Pages 151-162
Publisher
Bentham Science Publishers Ltd.
Online
2012-04-28
DOI
10.2174/187152012799015002

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now